tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vaccinex reports Q2 EPS (12c) vs (13c) last year

Cash and Cash Equivalents and Marketable Securities. Cash and cash equivalents and marketable securities on June 30, 2023 were $1.9 million, as compared to $6.4 million as of December 31, 2022.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on VCNX:

Disclaimer & DisclosureReport an Issue

1